Clinical trial
Transcorneal Electrical Stimulation for the Treatment of Retinitis Pigmentosa - a Multicenter Safety Study of the Okustim ® System
NCT01835002 is registered in ClinicalTrials.gov with Okuvision GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Transcorneal Electrical Stimulation for the Treatment of Retinitis Pigmentosa - a Multicenter Safety Study of the Okustim ® System
- Lead sponsor
- Okuvision GmbH
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2012
- Completion date
- August 31, 2015
- Enrollment
- 105 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.